$FORA
Forian Inc.

2020 Form 10-K Financial Statement

#000114036121011044 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2020 2019 Q4 2019 Q2
Revenue $544.9K $15.29M $1.650M
YoY Change -96.44% 59.94% -11.76%
Cost Of Revenue $38.29K $8.180M $350.0K
YoY Change -99.53% 37.02% -71.31%
Gross Profit $506.6K $7.110M $1.300M
YoY Change -92.88% 98.05% 100.0%
Gross Profit Margin 92.97% 46.5% 78.79%
Selling, General & Admin $2.981M $12.53M $2.570M
YoY Change -76.21% 18.54% 49.42%
% of Gross Profit 588.39% 176.23% 197.69%
Research & Development $2.510M
YoY Change
% of Gross Profit 495.42%
Depreciation & Amortization $8.555K $4.780M $1.190M
YoY Change -99.82% 54.69% 38.37%
% of Gross Profit 1.69% 67.23% 91.54%
Operating Expenses $5.490M $17.33M $3.750M
YoY Change -68.32% 26.96% 44.79%
Operating Profit -$4.984M -$10.22M -$2.450M
YoY Change -51.24% 1.59% 26.29%
Interest Expense $0.00 -$1.680M -$510.0K
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $3.574K $2.320M $7.790M
YoY Change -99.85% 7.91% 1670.45%
Pretax Income -$4.980M -$9.580M $4.830M
YoY Change -48.01% 20.2% -502.5%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.980M -$9.580M $4.810M
YoY Change -48.01% 20.2% -157.26%
Net Earnings / Revenue -914.01% -62.66% 291.52%
Basic Earnings Per Share -$0.38
Diluted Earnings Per Share -$0.38 -$119.4K $0.07
COMMON SHARES
Basic Shares Outstanding 13.19M
Diluted Shares Outstanding 13.19M

Balance Sheet

Concept 2020 2019 Q4 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.17M $650.0K $800.0K
YoY Change 1772.31% 124.14% 81.82%
Cash & Equivalents $494.00 $0.00
Short-Term Investments $11.50M
Other Short-Term Assets $120.0K $740.0K $540.0K
YoY Change -83.78% 80.49%
Inventory $260.0K $10.00K
Prepaid Expenses $25.37K
Receivables $220.0K $0.00 $1.640M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.51M $175.6K $2.990M
YoY Change 255.4% -90.85% 92.9%
LONG-TERM ASSETS
Property, Plant & Equipment $50.00K $3.419K $1.840M
YoY Change -97.37% -99.02% 636.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $80.00K $120.0K
YoY Change -46.67% -74.47%
Total Long-Term Assets $40.00K $3.419K $59.09M
YoY Change -99.94% -99.99% -2.07%
TOTAL ASSETS
Total Short-Term Assets $12.51M $175.6K $2.990M
Total Long-Term Assets $40.00K $3.419K $59.09M
Total Assets $12.55M $179.0K $62.08M
YoY Change -82.97% -99.71% 0.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $650.0K $6.400K $860.0K
YoY Change -27.78% -99.24% -38.57%
Accrued Expenses $480.0K $269.4K $1.610M
YoY Change -79.75% -68.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $300.0K $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $2.440M $1.840M
YoY Change -100.0% 1061.9% 636.0%
Total Short-Term Liabilities $1.290M $460.1K $6.710M
YoY Change -81.39% -88.94% 112.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $820.0K $40.00K
YoY Change -100.0% 1540.0% -55.56%
Other Long-Term Liabilities $780.0K $960.0K
YoY Change
Total Long-Term Liabilities $0.00 $1.600M $1.000M
YoY Change -100.0% 3100.0% 1011.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.290M $460.1K $6.710M
Total Long-Term Liabilities $0.00 $1.600M $1.000M
Total Liabilities $1.290M $8.540M $7.710M
YoY Change -84.89% 102.85% 137.23%
SHAREHOLDERS EQUITY
Retained Earnings -$1.289M
YoY Change
Common Stock $7.713K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.27M -$281.0K $0.00
YoY Change
Total Liabilities & Shareholders Equity $12.55M $179.0K $62.08M
YoY Change -82.97% -99.71% 0.31%

Cashflow Statement

Concept 2020 2019 Q4 2019 Q2
OPERATING ACTIVITIES
Net Income -$4.980M -$9.580M $4.810M
YoY Change -48.01% 20.2% -157.26%
Depreciation, Depletion And Amortization $8.555K $4.780M $1.190M
YoY Change -99.82% 54.69% 38.37%
Cash From Operating Activities -$4.251M -$3.420M -$710.0K
YoY Change 24.29% -10.24% 16.39%
INVESTING ACTIVITIES
Capital Expenditures $51.49K -$1.070M $510.0K
YoY Change -104.81% 568.75% 27.5%
Acquisitions
YoY Change
Other Investing Activities -$11.35M -$150.0K -$90.00K
YoY Change 7466.67% -137.5% -121.43%
Cash From Investing Activities -$11.40M -$1.220M -$610.0K
YoY Change 834.43% -608.33% -2133.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.32M 5.210M 90.00K
YoY Change 213.16% 73.09% -86.15%
NET CHANGE
Cash From Operating Activities -4.251M -3.420M -710.0K
Cash From Investing Activities -11.40M -1.220M -610.0K
Cash From Financing Activities 16.32M 5.210M 90.00K
Net Change In Cash 665.0K 570.0K -1.230M
YoY Change 16.66% -201.79% -1857.14%
FREE CASH FLOW
Cash From Operating Activities -$4.251M -$3.420M -$710.0K
Capital Expenditures $51.49K -$1.070M $510.0K
Free Cash Flow -$4.302M -$2.350M -$1.220M
YoY Change 83.07% -35.62% 20.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1184300
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
647601
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6400
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22996
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
269376
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
480741
CY2020Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
8825
CY2019Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
227593
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
854
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9409
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17514907
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1000098
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
882
CY2019Q4 us-gaap Assets
Assets
179045
CY2020Q4 us-gaap Assets
Assets
12554341
CY2019Q4 us-gaap Assets Current
AssetsCurrent
175626
CY2020Q4 us-gaap Assets Current
AssetsCurrent
12507983
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
494
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
665463
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
863409
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2606
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0
CY2020 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
665463
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
494
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
664969
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
494
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7713528
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21233039
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7713528
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21233039
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
21233
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
7713
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
CY2020 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
184300
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
158884
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-weight: bold;">Customer Concentration</div><div>&#160;</div><div style="text-indent: 36pt;">For the year ended December 31, 2020, the Company had a single customer that accounted for $450,000 of revenue, which represented 83% of revenues generated from customer sales. The Company believes that this customer is ultimately replaceable, and any disruption associated with this customer would only have a short-term impact on the business.&#160; The contracts assets balance for this customer at December 31, 2020 was $142,917.</div><div>&#160;</div><div style="text-indent: 36pt;">The Company regularly reviews outstanding accounts receivable for collectability and records an allowance for doubtful accounts, if determined to be necessary.&#160; Management determined that a reserve was not necessary as of December 31, 2020.</div></div>
CY2020 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
223750
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
158884
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
196701
CY2020 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
334092
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38293
CY2020 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Depreciation
Depreciation
8555
us-gaap Depreciation
Depreciation
854
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
641201
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22996
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
196701
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6400
CY2020 us-gaap Gross Profit
GrossProfit
506578
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
346720
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39177
us-gaap Gross Profit
GrossProfit
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1288842
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4980183
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
25365
us-gaap Interest Paid Net
InterestPaidNet
0
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
95614
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
211365
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
266770
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
158884
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Investment Income Net
InvestmentIncomeNet
3330
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
3574
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
805675
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
272187
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
533488
CY2020 us-gaap Lease Cost
LeaseCost
16106
us-gaap Lease Cost
LeaseCost
4289
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12554341
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
179045
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
460076
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1287226
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
149767
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11501844
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1032372
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4250734
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-4980183
us-gaap Net Income Loss
NetIncomeLoss
-1288842
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151434
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11399997
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16315700
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3330
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3574
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
184300
us-gaap Operating Expenses
OperatingExpenses
1292172
CY2020 us-gaap Operating Expenses
OperatingExpenses
5490335
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-4983757
us-gaap Operating Income Loss
OperatingIncomeLoss
-1292172
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
30822
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
25365
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2606
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
149767
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11348503
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1667
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51494
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
120979
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25365
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1000000
CY2020 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
16315700
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
184300
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55767
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4273
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46358
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3419
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2509666
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
827474
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1288842
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6269025
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
544871
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2980669
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
464698
CY2020Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
125196
CY2019Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
0
us-gaap Share Based Compensation
ShareBasedCompensation
7811
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
28329
CY2020 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.7776
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-281031
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11267115
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-weight: bold;">Use of Estimates</div><div>&#160;</div><div style="text-indent: 36pt;">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses together with amounts disclosed in related notes to the financial statements. The Company&#8217;s significant estimates used in these financial statements include, but are not limited to, fair value for equity securities and stock-based compensation. Certain of the Company&#8217;s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is possible that the external factors could have an effect on the Company estimates and could cause actual results to differ from those estimates.</div></div>
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13189623
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4739471
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q2 dei Entity Public Float
EntityPublicFloat
0
CY2020 dei Entity Registrant Name
EntityRegistrantName
Forian Inc.
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001829280
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31351265
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
fora Realized And Unrealized Gains Losses On Investments
RealizedAndUnrealizedGainsLossesOnInvestments
0
CY2020 fora Realized And Unrealized Gains Losses On Investments
RealizedAndUnrealizedGainsLossesOnInvestments
3574
CY2020 fora Contract With Customer Asset Revenue Recognized
ContractWithCustomerAssetRevenueRecognized
366667
CY2020 fora Number Of Legal Firms
NumberOfLegalFirms
1
CY2020 fora Legal Fees Percentage Of Operating Expenses
LegalFeesPercentageOfOperatingExpenses
0.12
CY2020 fora Licensing Fees Percentage Of Operating Expenses
LicensingFeesPercentageOfOperatingExpenses
0.05
fora Licensing Fees Percentage Of Operating Expenses
LicensingFeesPercentageOfOperatingExpenses
0.42
fora Technical Infrastructure Fees Percentage Of Operating Expenses
TechnicalInfrastructureFeesPercentageOfOperatingExpenses
0.17
CY2020 fora Technical Infrastructure Fees Percentage Of Operating Expenses
TechnicalInfrastructureFeesPercentageOfOperatingExpenses
0.06
CY2020 fora Number Of Revenue Generating Offerings
NumberOfRevenueGeneratingOfferings
2
CY2020 fora Contract With Customer Performance Obligation Term Of Payment
ContractWithCustomerPerformanceObligationTermOfPayment
P30D
CY2020 fora Contract With Customer Liability Revenue Recognized During Year
ContractWithCustomerLiabilityRevenueRecognizedDuringYear
175208
CY2020 fora Contract With Customer Asset Capitalized Acquisition Cost
ContractWithCustomerAssetCapitalizedAcquisitionCost
53784
fora Contract With Customer Asset Capitalized Acquisition Cost
ContractWithCustomerAssetCapitalizedAcquisitionCost
0
CY2020Q4 fora Prepaid Expense License Agreements
PrepaidExpenseLicenseAgreements
90157
CY2020 fora Number Of Short Term Leases
NumberOfShortTermLeases
2

Files In Submission

Name View Source Status
0001140361-21-011044-index-headers.html Edgar Link pending
0001140361-21-011044-index.html Edgar Link pending
0001140361-21-011044.txt Edgar Link pending
0001140361-21-011044-xbrl.zip Edgar Link pending
brhc10022145_10k.htm Edgar Link pending
brhc10022145_ex10-3.htm Edgar Link pending
brhc10022145_ex10-4.htm Edgar Link pending
brhc10022145_ex10-5.htm Edgar Link pending
brhc10022145_ex10-6.htm Edgar Link pending
brhc10022145_ex10-7.htm Edgar Link pending
brhc10022145_ex23-1.htm Edgar Link pending
brhc10022145_ex31-1.htm Edgar Link pending
brhc10022145_ex31-2.htm Edgar Link pending
brhc10022145_ex32-1.htm Edgar Link pending
brhc10022145_ex4-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fora-20201231.xml Edgar Link completed
fora-20201231.xsd Edgar Link pending
fora-20201231_cal.xml Edgar Link unprocessable
fora-20201231_def.xml Edgar Link unprocessable
fora-20201231_lab.xml Edgar Link unprocessable
fora-20201231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending